The clinical trial of an alkylating agent with a short half-life designed for intra-arterial chemotherapy.
D000433:1-Propanol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D001565:Benzoates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D006801:Humans
D000477:Alkylating Agents; D001565:Benzoates; D000433:1-Propanol